President Trump’s pick to lead the Food and Drug Administration dodged a key question on whether he will adopt reforms Trump touted on the campaign trail to lower high drug prices.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.